These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1347255)
1. Proceedings of the Second Joint WHO/ISH Symposium on the Prevention of Hypertension and Cardiovascular Disease, Camoglia, Italy, June 1-3, 1991. Clin Exp Hypertens A; 1992; 14(1-2):1-341. PubMed ID: 1347255 [No Abstract] [Full Text] [Related]
2. Proceedings of the joint WHO/ISH symposium on the Prevention of Hypertension and Cardiovascular Disease. Gothenburg, Sweden, September 4-6, 1989. Clin Exp Hypertens A; 1990; 12(5):693-956. PubMed ID: 2208744 [No Abstract] [Full Text] [Related]
3. Proceedings of the 3rd WHO/ISH meeting on prevention of hypertension and cardiovascular disease. Porto Cervo, Italy, June 15-17, 1995. Clin Exp Hypertens; 1996; 18(3-4):vii-xv, 267-593. PubMed ID: 8845833 [No Abstract] [Full Text] [Related]
4. Prevention of hypertension and associated cardiovascular disease: a 1991 statement. Conclusions from a joint WHO/ISH meeting. Clin Exp Hypertens A; 1992; 14(1-2):333-41. PubMed ID: 1541044 [No Abstract] [Full Text] [Related]
5. Cardiovascular Consequences of Hypertension: The Effects of Antihypertensive Therapy. Proceedings of a satellite symposium to the 6th European Meeting on Hypertension. Milan, Italy, June 1993. Blood Press Suppl; 1994; 1():1-80. PubMed ID: 7911379 [No Abstract] [Full Text] [Related]
6. Prevention of hypertension and associated cardiovascular disease. A 1995 statement. Conclusions from a joint WHO/ISH Meeting. Clin Exp Hypertens; 1996; 18(3-4):581-93. PubMed ID: 8743045 [No Abstract] [Full Text] [Related]
7. Predictive preventive medicine for hypertensive cardiovascular disease. Proceedings of satellite symposium to WHO Forum '97. Kyoto, Japan, October 1997. Clin Exp Pharmacol Physiol; 1999 Jul; 26(7):527-80. PubMed ID: 10454859 [No Abstract] [Full Text] [Related]
8. Proceedings of the Joint WHO/ISH Symposium on Hypertension and Cardiovascular Disease. Paris, March 28-31, 1993. Clin Exp Hypertens; 1993 Nov; 15(6):911-1395. PubMed ID: 8268897 [No Abstract] [Full Text] [Related]
9. Cardiovascular forum. A Ciba symposium. Heidelberg, Germany, 3-5 October 1996. Proceedings. Br J Hosp Med; 1996 Nov 20-Dec 10; 56(10):542-7. PubMed ID: 8958409 [No Abstract] [Full Text] [Related]
10. Proceedings of the joint WHO/ISH Symposium on Hypertension and Cardiovascular Disease. Melbourne, Australia, December 4th to 7th, 1988. Clin Exp Hypertens A; 1989; 11(5-6):753-1216. PubMed ID: 2791326 [No Abstract] [Full Text] [Related]
11. From vascular protection to secondary prevention in cardiovascular diseases. Proceedings of satellite symposium to the 16th Scientific Meeting of the International Society of Hypertension. Glasgow, United Kingdom, 23 June 1996. J Hypertens Suppl; 1996 Dec; 14(6):S1-53. PubMed ID: 9091612 [No Abstract] [Full Text] [Related]
12. Antihypertensive treatment: prevention of cardiovascular disease and prevention of events. Satellite symposium to the 5th European Meeting on Hypertension. Milan, Italy, June 7-10, 1991. J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S1-104. PubMed ID: 1376825 [No Abstract] [Full Text] [Related]
13. Reversing the Cardiovascular Disease Epidemic Among Ethnic Minority Populations: Translating Strategies into Success. 17th Annual International Interdisciplinary Conference on Hypertension and Related Risk Factors in Ethnic Populations. June 8-12, 2002, Miami, Florida, USA. Proceedings and abstracts. Ethn Dis; 2002; 12(4):S3-1-156. PubMed ID: 12622109 [No Abstract] [Full Text] [Related]
14. 1991 guidelines for the prevention of hypertension and associated cardiovascular disease. Joint World Health Organization/International Society of Hypertension Meeting. J Hypertens; 1992 Jan; 10(1):97-9. PubMed ID: 1312559 [No Abstract] [Full Text] [Related]
15. ACE inhibitors and end-organ damage in cardiovascular disease: vessel-wall damage and cardiac function in hypertension. Proceedings of the Erasmus Medical Workshops. J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S1-139. PubMed ID: 1381783 [No Abstract] [Full Text] [Related]
16. ACE inhibitors and end-organ damage in cardiovascular disease: kidney and nervous system in hypertension. Proceedings of the Erasmus Medical Workshops. J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S1-145. PubMed ID: 1382154 [No Abstract] [Full Text] [Related]
17. Is hypertension a fatal disease today? Proceedings of a satellite symposium held during the 21st European Meeting on Hypertension and Cardiovascular Prevention Milan (Italy), June 17-20, 2011. Foreword. Zanchetti A J Hypertens; 2011 Dec; 29 Suppl 1():S1. PubMed ID: 22157562 [No Abstract] [Full Text] [Related]
18. The Management of Hypertension and Prevention of Cardiac Complications Using Calcium Antagonists. Proceedings of the 1st International Nifedipine GITS Symposium, Cannes, February 28, 1992 and of a satellite symposium to the 14th ISH Congress, Madrid, June 14, 1992. J Cardiovasc Pharmacol; 1993; 21 Suppl 2():S1-66. PubMed ID: 7692144 [No Abstract] [Full Text] [Related]
19. [Cardiovascular epidemiology in Italy in the 70's]. Menotti A G Ital Cardiol; 1981; 11 Suppl 1():42-53. PubMed ID: 7035276 [No Abstract] [Full Text] [Related]
20. Breakthrough against hypertensive and atherosclerotic disease? Some possible implications and problems for cardiovascular research and clinical practice. STAMLER J Geriatrics; 1962 Jan; 17():31-40. PubMed ID: 13916150 [No Abstract] [Full Text] [Related] [Next] [New Search]